Lower Extremity Amputation Clinical Trial
— MOVE-LEAPOfficial title:
Home-based Weight Loss Intervention for Individuals With Lower Extremity Amputation
NCT number | NCT02085785 |
Other study ID # | F6982-Wa |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 20, 2014 |
Est. completion date | May 1, 2018 |
Verified date | May 2018 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to pilot test a program to help overweight and obese individuals
with a lower extremity amputation (LEA) lose weight and become more physically active. The
investigators will randomize approximately 30 individuals to either a self-directed weight
loss program (n=15) or a coached weight loss program (n=15). The primary purpose of this
pilot study is to determine if a home-based weight loss/physical activity (PA) intervention
is feasible in individuals with a LEA. MOVE-LEAP is a 20-week program that involves 11 phone
calls from a health coach and a single home visit by a physical therapist.
This pilot study aims to:
1. test the feasibility of recruiting overweight/obese individuals with LEA into a
randomized trial;
2. assess whether the intervention can be delivered with high fidelity, and
3. evaluate whether the intervention is acceptable to and safe as determined by participant
feedback, participation and retention for outcome measures.
Status | Completed |
Enrollment | 15 |
Est. completion date | May 1, 2018 |
Est. primary completion date | November 16, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 69 Years |
Eligibility |
Inclusion Criteria: - Lower extremity amputation (including toes) for at least 1 year - overweight or obese - <60 minutes drive-time to VA Puget Sound Health Care System - Seattle campus, willing to be randomized - provides written, informed consent - able to perform some form of aerobic exercise (e.g., walking, bicycling, swimming) - has telephone - able to complete study assessments Exclusion Criteria: - Co-morbidities which may be contraindicated or indicate no potential benefit from weight loss or increasing physical activity - unlikely to be able to adhere to study protocol and complete questionnaires and measurements reliably - recent or current (last 6 months) participation in a weight loss program, including taking weight loss medications - only uses motorized (non-manual) wheelchair |
Country | Name | City | State |
---|---|---|---|
United States | VA Puget Sound Health Care System Seattle Division, Seattle, WA | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Individuals That Were Randomized of Those Contacted (Feasibility) | Specific components include yield by method, recruitment rate, refusal rates and reasons | During recruitment (expected duration of 12-15 months) | |
Secondary | Feasibility - Retention | Number of randomized individuals who complete baseline and study exit visit | Follow-up assessments (all participants) and during intervention (intervention group only) (weekly, for 20 weeks) | |
Secondary | Acceptability | Acceptability of intervention will be assessed via a brief satisfaction survey - % who would recommend the program to a friend | At follow-up assessment (20-weeks follow-up) | |
Secondary | Change in Weight | Changes between baseline and 20-weeks later (end of intervention) | Baseline and follow-up assessment (20-weeks after randomization) | |
Secondary | Change in 6-minute Walk Distance | Change in 6-minute walk distance (ft) from baseline to follow-up | Baseline and at follow-up assessment (20-weeks after randomization) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04017221 -
Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
|
||
Completed |
NCT03592316 -
Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients
|
N/A | |
Recruiting |
NCT05989113 -
Psychometric Qualities IPAQ-SF
|
||
Completed |
NCT02440295 -
Pilot Study to Assess the Use of Spy Elite for Assessment of Amputation Healing
|
||
Enrolling by invitation |
NCT06371209 -
Kinematics of Ewing Amputees
|
||
Completed |
NCT03703232 -
Community Walking Trials: Comparing Prosthetic Feet
|
N/A | |
Recruiting |
NCT04934839 -
Instrumental Analysis of Walking in People With Osseointegrated Prostheses for Lower Extremity Amputation: Comparative Evaluation With Traditional Socket Prostheses
|
N/A | |
Recruiting |
NCT05884203 -
Improving Prosthetic Provision in Rural Communities: Limb Scanning With Caregiver Assistance
|
N/A | |
Completed |
NCT02440282 -
Comparison of Anesthetic Modalities on Hemodynamic Stability and Postoperative Pain in Diabetic Foot Patients Undergoing Minor Lower Extremity Amputation
|
N/A | |
Active, not recruiting |
NCT03900845 -
Adherence and Perspiration While Wearing Lower Limb Prostheses
|
N/A | |
Recruiting |
NCT03532100 -
Pivot-Flex Foot: Optimal Coupling Ratio Between Transverse and Sagittal-plane Motions Using a Torsionally Adaptive Prosthesis for Individuals With Lower Limb Amputation
|
N/A |